| scholarly article | Q13442814 |
| P2093 | author name string | Marta Kisiel | |
| Curt Pettersson | |||
| Pernilla Videhult Pierre | |||
| Anette E Fransson | |||
| Göran F E Laurell | |||
| Kristian Pirttilä | |||
| P2860 | cites work | HMDB: the Human Metabolome Database | Q23039065 |
| NIH Image to ImageJ: 25 years of image analysis | Q23319322 | ||
| Intratympanic gentamicin for Ménière's disease or syndrome | Q24235857 | ||
| HMDB 3.0--The Human Metabolome Database in 2013 | Q24595162 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity | Q27335267 | ||
| An integrated view of cisplatin-induced nephrotoxicity and ototoxicity | Q28080615 | ||
| METLIN: a metabolite mass spectral database | Q29614808 | ||
| XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification | Q29616057 | ||
| Immunohistochemical localization of OCT2 in the cochlea of various species. | Q30368484 | ||
| Inhalation of hydrogen gas attenuates ouabain-induced auditory neuropathy in gerbils | Q30430570 | ||
| Hydrogen-saturated saline protects intensive narrow band noise-induced hearing loss in guinea pigs through an antioxidant effect | Q30436129 | ||
| Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions | Q30476563 | ||
| Role of the copper transporter, CTR1, in platinum-induced ototoxicity | Q30477867 | ||
| Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis | Q30479250 | ||
| Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models | Q31137205 | ||
| Investigation of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using blood oxygenation level-dependent magnetic resonance imaging | Q34007094 | ||
| Antioxidants accelerate lung cancer progression in mice | Q34400895 | ||
| Mechanisms of cisplatin ototoxicity and progress in otoprotection | Q36933156 | ||
| Recent advances in hydrogen research as a therapeutic medical gas. | Q37785099 | ||
| Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update | Q37989844 | ||
| Membrane transporters as determinants of the pharmacology of platinum anticancer drugs. | Q38026121 | ||
| Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: a meta-analysis of randomized, controlled trials | Q38301183 | ||
| Pathophysiology of the cochlear intrastrial fluid-blood barrier (review). | Q38708802 | ||
| Antioxidants can increase melanoma metastasis in mice | Q38829594 | ||
| Cochlear synaptopathy in acquired sensorineural hearing loss: Manifestations and mechanisms | Q39087848 | ||
| Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial | Q40443233 | ||
| Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin. | Q40600080 | ||
| Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT. | Q41811232 | ||
| Cochlear pharmacokinetics of cisplatin: an in vivo study in the guinea pig. | Q42439712 | ||
| Immunocytochemical detection of synaptophysin in C57BL/6 mice cochlea during aging process | Q42456219 | ||
| Inhaled hydrogen gas therapy for prevention of noise-induced hearing loss through reducing reactive oxygen species | Q42465173 | ||
| Morphological and functional preservation of the outer hair cells from noise trauma by sound conditioning | Q46160071 | ||
| Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice | Q46160302 | ||
| Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. | Q46183250 | ||
| Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. | Q46204838 | ||
| The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study | Q46215201 | ||
| Molecular mechanisms underlying the protective effects of hydrogen-saturated saline on noise-induced hearing loss | Q46235422 | ||
| Hydrogen-rich saline alleviates experimental noise-induced hearing loss in guinea pigs | Q46461973 | ||
| Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. | Q46768393 | ||
| Medial olivocochlear efferent terminals are protected by sound conditioning | Q46885201 | ||
| Cisplatin-induced metabolome changes in serum: an experimental approach to identify markers for ototoxicity | Q46891118 | ||
| Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals | Q48175944 | ||
| Hydrogen supplemented air inhalation reduces changes of prooxidant enzyme and gap junction protein levels after transient global cerebral ischemia in the rat hippocampus. | Q49107249 | ||
| Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress. | Q50432585 | ||
| Hydrogen in drinking water attenuates noise-induced hearing loss in guinea pigs. | Q50436365 | ||
| Hydrogen protects auditory hair cells from free radicals. | Q53361254 | ||
| A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. | Q53588029 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation | Q57088084 | ||
| Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients | Q57500252 | ||
| Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig | Q72163488 | ||
| Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress | Q80730143 | ||
| Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits | Q83080231 | ||
| Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release | Q85057423 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | ototoxicity | Q1351381 |
| P304 | page(s) | 280 | |
| P577 | publication date | 2017-09-13 | |
| P1433 | published in | Frontiers in Cellular Neuroscience | Q2131509 |
| P1476 | title | Hydrogen Inhalation Protects against Ototoxicity Induced by Intravenous Cisplatin in the Guinea Pig. | |
| P478 | volume | 11 |
| Q90595610 | Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies |
| Q90512458 | An LCMS-based untargeted metabolomics protocol for cochlear perilymph: highlighting metabolic effects of hydrogen gas on the inner ear of noise exposed Guinea pigs |
| Q89910510 | Hydrogen Gas Attenuates Hypoxic-Ischemic Brain Injury via Regulation of the MAPK/HO-1/PGC-1a Pathway in Neonatal Rats |
| Q91781317 | Middle Ear Administration of a Particulate Chitosan Gel in an in vivo Model of Cisplatin Ototoxicity |
| Q93143450 | Pharmacological intervention in the field of ototoxicity |
| Q64092824 | Use of Gases to Treat Cochlear Conditions |
Search more.